Latest Articles
miRNA Expression Haplotype in Hispanics with Endometriosis - Frontiers
miRNA Expression Haplotype in Hispanics with Endometriosis Frontiers
Published: Sept. 8, 2025, 10:23 a.m.
Pelvic Venous and Pulmonary Artery Extension in Low-Grade Endometrial Stromal Sarcoma: A Case Report - Frontiers
Pelvic Venous and Pulmonary Artery Extension in Low-Grade Endometrial Stromal Sarcoma: A Case Report Frontiers
Published: Sept. 8, 2025, 10:19 a.m.
Transition-year student with endometriosis working on Junk Kouture project to spread awareness of condition - The Irish Independent
Transition-year student with endometriosis working on Junk Kouture project to spread awareness of condition The Irish Independent
Published: Sept. 8, 2025, 4:30 a.m.
‘When I got the diagnosis I was relieved’ – student (15) with endometriosis working on Junk Kouture project to spread awareness - The Irish Independent
‘When I got the diagnosis I was relieved’ – student (15) with endometriosis working on Junk Kouture project to spread awareness The Irish Independent
Published: Sept. 8, 2025, 4:30 a.m.
Pipelle Endometrial Biopsy Versus Conventional Dilation and Curettage for the Diagnosis of Endometrial Pathology in Abnormal Uterine Bleeding - Cureus
Pipelle Endometrial Biopsy Versus Conventional Dilation and Curettage for the Diagnosis of Endometrial Pathology in Abnormal Uterine Bleeding Cureus
Published: Sept. 8, 2025, 1:03 a.m.
Gilead Sciences Advances Endometrial Cancer Treatment with New Phase 3 Study - TipRanks
Gilead Sciences Advances Endometrial Cancer Treatment with New Phase 3 Study TipRanks
Published: Sept. 7, 2025, 5:31 p.m.
Belfast woman felt 'crazy' waiting for endometriosis diagnosis - Rayo
Belfast woman felt 'crazy' waiting for endometriosis diagnosis Rayo
Published: Sept. 7, 2025, 7:27 a.m.
Endometrial cancer: new markers for PET imaging - healthcare-in-europe.com
Endometrial cancer: new markers for PET imaging healthcare-in-europe.com
Published: Sept. 7, 2025, 6:23 a.m.
Genmab (CPSE:GMAB) Is Up 10.3% After FDA Breakthrough for Rina-S in Endometrial Cancer – Has The Bull Case Changed? - Yahoo Finance
Genmab (CPSE:GMAB) Is Up 10.3% After FDA Breakthrough for Rina-S in Endometrial Cancer – Has The Bull Case Changed? Yahoo Finance
Published: Sept. 6, 2025, 11:31 a.m.
AbbVie’s Phase 3b Study on Elagolix: A Potential Game-Changer for Endometriosis Treatment? - TipRanks
AbbVie’s Phase 3b Study on Elagolix: A Potential Game-Changer for Endometriosis Treatment? TipRanks
Published: Sept. 6, 2025, 4:33 a.m.
Link copied to clipboard!